Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors.

Wang P, Burikhanov R, Jayswal R, Weiss HL, Arnold SM, Villano JL, Rangnekar VM.

Genes Cancer. 2018 May;9(5-6):190-197. doi: 10.18632/genesandcancer.181.

2.

A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Hebbar N, Burikhanov R, Shukla N, Qiu S, Zhao Y, Elenitoba-Johnson KSJ, Rangnekar VM.

Cancer Res. 2017 Aug 1;77(15):4039-4050. doi: 10.1158/0008-5472.CAN-16-1970. Epub 2017 Jun 16.

3.

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis.

Burikhanov R, Hebbar N, Noothi SK, Shukla N, Sledziona J, Araujo N, Kudrimoti M, Wang QJ, Watt DS, Welch DR, Maranchie J, Harada A, Rangnekar VM.

Cell Rep. 2017 Jan 10;18(2):508-519. doi: 10.1016/j.celrep.2016.12.051.

4.

Par-4 secretion: stoichiometry of 3-arylquinoline binding to vimentin.

Sviripa VM, Burikhanov R, Obiero JM, Yuan Y, Nickell JR, Dwoskin LP, Zhan CG, Liu C, Tsodikov OV, Rangnekar VM, Watt DS.

Org Biomol Chem. 2016 Jan 7;14(1):74-84. doi: 10.1039/c5ob01980j.

5.

Development of 6H-Chromeno[3,4-c]pyrido[3',2':4,5]thieno[2,3-e]pyridazin-6-ones as Par-4 Secretagogues.

Frasinyuk MS, Bondarenko SP, Sviripa VM, Burikhanov R, Rangnekar VM, Liu C, Watt DS.

Tetrahedron Lett. 2015 Jun 3;56(23):3382-3384.

6.

Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis.

Burikhanov R, Sviripa VM, Hebbar N, Zhang W, Layton WJ, Hamza A, Zhan CG, Watt DS, Liu C, Rangnekar VM.

Nat Chem Biol. 2014 Nov;10(11):924-926. doi: 10.1038/nchembio.1631. Epub 2014 Sep 14.

7.

Paracrine apoptotic effect of p53 mediated by tumor suppressor Par-4.

Burikhanov R, Shrestha-Bhattarai T, Hebbar N, Qiu S, Zhao Y, Zambetti GP, Rangnekar VM.

Cell Rep. 2014 Jan 30;6(2):271-7. doi: 10.1016/j.celrep.2013.12.020. Epub 2014 Jan 9.

8.

Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells.

Pereira MC, de Bessa-Garcia SA, Burikhanov R, Pavanelli AC, Antunes L, Rangnekar VM, Nagai MA.

Int J Oncol. 2013 Aug;43(2):531-8. doi: 10.3892/ijo.2013.1983. Epub 2013 Jun 12.

9.

Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM.

Cancer Res. 2013 Jan 15;73(2):1011-9. doi: 10.1158/0008-5472.CAN-12-3212. Epub 2012 Nov 30.

10.

Systemic Par-4 inhibits non-autochthonous tumor growth.

Zhao Y, Burikhanov R, Brandon J, Qiu S, Shelton BJ, Spear B, Bondada S, Bryson S, Rangnekar VM.

Cancer Biol Ther. 2011 Jul 15;12(2):152-7. Epub 2011 Jul 15.

11.

The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.

Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM.

Cell. 2009 Jul 23;138(2):377-88. doi: 10.1016/j.cell.2009.05.022. Erratum in: Cell. 2009 Sep 4;138(5):1032.

12.

Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis.

Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM.

Mol Cancer Ther. 2008 Sep;7(9):2884-93. doi: 10.1158/1535-7163.MCT-08-0438.

13.

Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Goswami A, Qiu S, Dexheimer TS, Ranganathan P, Burikhanov R, Pommier Y, Rangnekar VM.

Cancer Res. 2008 Aug 1;68(15):6190-8. doi: 10.1158/0008-5472.CAN-08-0831.

14.

Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma.

Shareef MM, Cui N, Burikhanov R, Gupta S, Satishkumar S, Shajahan S, Mohiuddin M, Rangnekar VM, Ahmed MM.

Cancer Res. 2007 Dec 15;67(24):11811-20.

15.

Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.

Vasudevan KM, Burikhanov R, Goswami A, Rangnekar VM.

Cancer Res. 2007 Nov 1;67(21):10343-50.

16.

Cancer resistance in transgenic mice expressing the SAC module of Par-4.

Zhao Y, Burikhanov R, Qiu S, Lele SM, Jennings CD, Bondada S, Spear B, Rangnekar VM.

Cancer Res. 2007 Oct 1;67(19):9276-85.

17.

Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.

Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D.

Cancer Res. 2007 Jan 1;67(1):246-53. Epub 2006 Dec 21.

18.

Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice.

Zhong J, Deaciuc IV, Burikhanov R, de Villiers WJ.

Biochim Biophys Acta. 2006 Apr;1762(4):468-77. Epub 2006 Feb 13.

19.

A herbal medicine for the treatment of lung cancer.

Ranga RS, Sowmyalakshmi S, Burikhanov R, Akbarsha MA, Chendil D.

Mol Cell Biochem. 2005 Dec;280(1-2):125-33.

PMID:
16311913
20.

Binding and phosphorylation of par-4 by akt is essential for cancer cell survival.

Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM.

Mol Cell. 2005 Oct 7;20(1):33-44.

21.

Microarray gene analysis of the liver in a rat model of chronic, voluntary alcohol intake.

Deaciuc IV, Peng X, D'Souza NB, Shedlofsky SI, Burikhanov R, Voskresensky IV, de Villiers WJ.

Alcohol. 2004 Feb;32(2):113-27.

PMID:
15163562
22.

Alcohol, but not lipopolysaccharide-induced liver apoptosis involves changes in intracellular compartmentalization of apoptotic regulators.

Deaciuc IV, D'Souza NB, Burikhanov R, Nasser MS, Voskresensky IV, De Villiers WJ, McClain CJ.

Alcohol Clin Exp Res. 2004 Jan;28(1):160-72.

PMID:
14745315
23.

Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion.

Deaciuc IV, Doherty DE, Burikhanov R, Lee EY, Stromberg AJ, Peng X, de Villiers WJ.

J Hepatol. 2004 Feb;40(2):219-27.

PMID:
14739091
24.

Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells.

El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM.

Mol Cell Biol. 2003 Aug;23(16):5516-25.

25.

Epidermal growth factor protects the liver against alcohol-induced injury and sensitization to bacterial lipopolysaccharide.

Deaciuc IV, D'Souza NB, Burikhanov R, Lee EY, Tarba CN, McClain CJ, de Villiers WJ.

Alcohol Clin Exp Res. 2002 Jun;26(6):864-74.

PMID:
12068256
26.

A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide.

Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ.

Alcohol Clin Exp Res. 2002 Jan;26(1):74-82.

PMID:
11821657
27.

Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide.

Deaciuc IV, D'Souza NB, de Villiers WJ, Burikhanov R, Sarphie TG, Hill DB, McClain CJ.

Alcohol Clin Exp Res. 2001 Jun;25(6):935-43.

PMID:
11410731
28.

Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.

Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S.

Endocr Regul. 2000 Dec;34(4):181-8.

PMID:
11137978
29.

Anti-goitrous effect of lecithin-bound iodine in propylthiouracil treated rats.

Matsuzaki S, Ma HT, Burikhanov RB.

Endocr Regul. 2000 Jun;34(2):57-63.

PMID:
10911406
30.

Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo.

Burikhanov RB, Matsuzaki S.

Thyroid. 2000 Feb;10(2):123-9.

PMID:
10718548
32.

Influence of immobilization stress on the level of secretion of thyroid hormones.

Turakulov YKh, Burikhanov RB, Patkhitdinov PP, Myslitskaya AI.

Neurosci Behav Physiol. 1994 Nov-Dec;24(6):462-4. No abstract available.

PMID:
7715764
33.

[Effect of immobilization stress on the level of thyroid hormone secretion].

Turakulov IaKh, Burikhanov RB, Patkhitdinov PP, Myslitskaia AI.

Probl Endokrinol (Mosk). 1993 Sep-Oct;39(5):47-8. Russian.

PMID:
8108351
34.

[Role of norepinephrine in the regulation of thyroid gland functional activity in rabbits].

Turakulov IaKh, Burikhanov RB.

Probl Endokrinol (Mosk). 1993 Jul-Aug;39(4):45-8. Russian.

PMID:
8415531
35.

[The effect of cryopreservation and transplantation factors on the morphofunctional state of the thyroid in dogs].

Ismailov SI, Turakulov IaKh, Tashkhodzhaeva TP, Shakhizirov D, Burikhanov RB.

Biull Eksp Biol Med. 1989 Dec;108(12):727-30. Russian.

PMID:
2634451
36.

[Changes in the ratio of secreted thyroid hormones under the action of adrenaline, propranolol and thyrotropic hormone].

Turakulov IaKh, Burikhanov RB, Tashkhodzhaeva TP, Ismailov SI, Artykbaeva GM.

Probl Endokrinol (Mosk). 1989 Nov-Dec;35(6):76-8. Russian.

PMID:
2622890
37.

[Extracorporeal biological perfusion of isolated canine thyroid glands].

Turakulov IaKh, Ismailov SI, Tashkhodzhaeva TP, Shakhizirov D, Burikhanov RB.

Biull Eksp Biol Med. 1986 Nov;102(11):618-20. Russian.

PMID:
3779096
38.

[Intrathyroid deiodination of thyroxine: the effect of thyrotropic hormone and denervation of the thyroid].

Turakulov IaKh, Tashkhodzhaeva TP, Burikhanov RB, Ismailov SI, Shakhizirov DSh.

Probl Endokrinol (Mosk). 1986 Sep-Oct;32(5):72-6. Russian.

PMID:
3786311

Supplemental Content

Loading ...
Support Center